Yan Wu

US Patent:

7400627, Jul 15, 2008

Filed:

Nov 7, 2003

Appl. No.:

10/702456

Inventors:

Yan Wu - Morganville NJ, US
Song Bi - Piscataway NJ, US
Timothy Bornemisza - Middletown NJ, US

Assignee:

Brooktree Broadband Holding, Inc. - Newport Beach CA

International Classification:

H04L 12/28
H04J 3/24

US Classification:

370392, 3703951, 370474

Abstract:

Disclosed are exemplary techniques for compressing ATM cells by substituting reduced headers for the original headers. A header table may be maintained at the transmitting end whereby headers are stored in table entries based on a table index generated from a hash function applied to the headers. A copy of the header table may be maintained at the receiving end and may be updated by populating idle cells with header table contents. Upon receipt of a reduced ATM cell at the receiving end, the reduced header may be replaced with a full header obtained from the copy of the header table maintained at the receiving end. The present invention further provides techniques for registration and management of hash collisions.

US Patent:

7692895, Apr 6, 2010

Filed:

Apr 10, 2006

Appl. No.:

11/401208

Inventors:

Yan Wu - Cupertino CA, US
Gang Herbert Lin - San Jose CA, US

Assignee:

Seagate Technology LLC - Scotts Valley CA

International Classification:

G11B 5/147

US Classification:

36012508

Abstract:

A magnetic head for perpendicular recording includes a main pole having a first end and a second end. Coils are positioned with respect to the main pole. A return pole forms first and second return paths for magnetic flux extending from the second end of the main pole. The main pole includes an anti-ferromagnetic layer to pin a remnant magnetic moment in the horizontal direction.

US Patent:

7720071, May 18, 2010

Filed:

Mar 5, 2008

Appl. No.:

12/042930

Inventors:

Yan Wu - Morganville NJ, US
Song Bi - Piscataway NJ, US
Timothy Bornemisza - Middletown NJ, US

Assignee:

Ikanos Communications, Inc. - Fremont CA

International Classification:

H04L 12/28
H04J 3/24

US Classification:

370392, 3703951, 370474

Abstract:

Disclosed are exemplary techniques for compressing ATM cells by substituting reduced headers for the original headers. A header table may be maintained at the transmitting end whereby headers are stored in table entries based on a table index generated from a hash function applied to the headers. A copy of the header table may be maintained at the receiving end and may be updated by populating idle cells with header table contents. Upon receipt of a reduced ATM cell at the receiving end, the reduced header may be replaced with a full header obtained from the copy of the header table maintained at the receiving end. The present invention further provides techniques for registration and management of hash collisions.

US Patent:

7803377, Sep 28, 2010

Filed:

Jun 6, 2007

Appl. No.:

11/759131

Inventors:

Minhong Yan - Foster City CA, US
Yan Wu - Foster City CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

A61K 39/395
C07K 16/00
C12P 21/00
A61P 35/00
C07H 21/00
C12N 1/00
C12N 5/00
G01N 33/68

US Classification:

4241451, 436 86, 5303871

Abstract:

The invention provides anti-DLL4 antibodies, and compositions comprising and methods of using these antibodies.

US Patent:

7813434, Oct 12, 2010

Filed:

Nov 14, 2006

Appl. No.:

11/559772

Inventors:

Yan Wu - Morganville NJ, US
Lujing Cai - Morganville NJ, US
William Scholtz - Red Bank NJ, US
Ehud Langberg - Wayside NJ, US

Assignee:

Ikanos Communications, Inc. - Fremont CA

International Classification:

H04K 1/10
H04L 27/28

US Classification:

375260

Abstract:

Systems and methods for performing bit loading in a dual latency data transmission system. In a computer network, such as an XDSL-based network, carrier channels are allocated between two latency paths. Error sensitive information is transmitted over a latency path employing one or more forward error correction techniques. Latency sensitive information that is relatively more tolerant of errors is transmitted over the other latency path. Rather than employing the lowest coding gain for carrier channels having the two different latency paths, the highest coding gain for each path is used by applying different target S-N-R margins for carrier channels having different latency paths.

US Patent:

7825221, Nov 2, 2010

Filed:

Aug 1, 2008

Appl. No.:

12/184969

Inventors:

Daniel K. Kirchhofer - Los Altos CA, US
Yan Wu - Foster City CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

C12P 21/08

US Classification:

5303873, 5303881, 5303917, 530350, 4241331

Abstract:

The invention provides methods and compositions for modulating hepatocyte growth factor activator function.

US Patent:

7834154, Nov 16, 2010

Filed:

Feb 8, 2008

Appl. No.:

12/028124

Inventors:

Alexander W. Koch - Millbrae CA, US
Scott Stawicki - San Francisco CA, US
Yan Wu - Foster City CA, US
Richard Carano - San Ramon CA, US
Ryan J. Watts - San Mateo CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

C07K 16/00
C07K 17/00
C07K 17/14
C12P 21/08
A61K 39/395
A61K 39/00

US Classification:

5303871, 5303873, 5303911, 5303913, 5303915, 4241301, 4241331, 4241341, 4241781

Abstract:

The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods.

US Patent:

7973138, Jul 5, 2011

Filed:

Sep 25, 2008

Appl. No.:

12/237640

Inventors:

Wei-Ching Liang - Foster City CA, US
Gregory D. Plowman - San Carlos CA, US
Yan Wu - Foster City CA, US
Weilan Ye - Foster City CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

C12P 21/08

US Classification:

5303873, 53038885, 5303911, 5303913, 5303917

Abstract:

The present invention relates to the use of VEGF antagonists and a novel anti-α5β1 antibody for treating cancer and inhibiting angiogenesis and/or vascular permability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to compositions and kits comprising novel anti-α5β1 antibodies and methods of making and using them.